Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ascend Wellness Holdings has the GF Score of 41, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Ascend Wellness Holdings
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Ascend Wellness Holdings GF Score Related Terms
FRA:8VJ vs ZTS, UTHR: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascend Wellness Holdings GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's GF Score distribution charts can be found below:
* The bar in red indicates where Ascend Wellness Holdings's GF Score falls into.
Ascend Wellness Holdings (FRA:8VJ) has a GF Score of 41 as of Jul. 16, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Ascend Wellness Holdings and its competitors. This is 15% below median its historical median of 48.00. Over the past decade, Ascend Wellness Holdings' GF Score has ranged from 19.00 to 64.00.
Is Ascend Wellness Holdings' GF Score too high?
Ascend Wellness Holdings' current GF Score of 41 is 15% below median its 10-year median of 48.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 64.00. Overall, Ascend Wellness Holdings has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' GF Score compare to ZTS and UTHR?
Ascend Wellness Holdings' GF Score of 41 can be compared against companies in the Drug Manufacturers industry. Historically, Ascend Wellness Holdings' own GF Score has ranged from 19.00 to 64.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Ascend Wellness Holdings and its competitors. Ascend Wellness Holdings's current GF Score is 41, which is 15% below median its own 10-year median of 48.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Ascend Wellness Holdings (FRA:8VJ) has a current GF Score of 41. The stock's GF Value™ is €0.58, compared to a current price of €0.38 — trading 34.1% below its estimated fair value. The current GF Score is 41, which is 15% below median its 10-year median of 48.00. Ascend Wellness Holdings' overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Ascend Wellness Holdings (FRA:8VJ), the current GF Score is 41 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascend Wellness Holdings (FRA:8VJ) Overvalued in 2026?
Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued.
The current stock price of €0.38 is trading 34.1% below its estimated GF Value™ of €0.58.
Key valuation signals for FRA:8VJ:
GF Score: 41 (15% below median its 10-year median of 48.00)
GF Value™: €0.58 vs. price of €0.38 (34.1% below fair value)
No single metric tells the full story. See the FRA:8VJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
41GF Score
Get the complete analysis for FRA:8VJ
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8VJ has been successfully added to your 
